Cassava Sciences | PTIE - 판매 및 관리 비용





판매 및 관리 비용 변화 날짜
Abbott USD 4.27B 669M 2026-09
Amgen USD 1.68B 40M 2026-09
Biogen USD 752M 42.3M 2026-09
Cara Therapeutics USD 2.09M 96K 2026-03
Cassava Sciences USD 3.37M 521K 2026-06
Eisai JPY 114.83B 4.71B 2026-06
Eli Lilly USD 3.12B 305M 2026-09
Geron USD 35.7M 3.16M 2026-09
J&J USD 6.25B 168M 2026-09
Merck USD 2.86B 25M 2026-09
Novartis USD 3.08B 163M 2026-09
Novavax USD 25.53M 1.34M 2025-12
Pfizer USD 3.28B 132M 2026-09
Roche Holding CHF 6.37B 908M 2026-06